Keyphrases
Multiple Sclerosis
90%
B Cells
39%
Relapsing-remitting multiple Sclerosis
36%
Progressive multiple Sclerosis
30%
T Cells
28%
Cerebrospinal Fluid
25%
Intrathecal
21%
Dimethyl Fumarate
20%
CD8+ T Cells
16%
Follicular Helper T Cells
15%
Myelin Basic Protein
13%
Natalizumab
12%
CD20+ T Cells
12%
Multiple Sclerosis Treatment
11%
CD4+ T Cells
10%
Migration Potential
10%
Cerebrospinal Fluid Biomarkers
10%
Flow Cytometry
10%
Cell-to-cell
10%
Inflammatory Biomarkers
10%
Cell Activity
9%
Soluble CD27
9%
T Helper 17 (Th17)
9%
Cladribine
9%
Tfh Cells
9%
Healthy Individuals
9%
Anti-CD20 Therapy
9%
Memory T Cells
9%
IL2RA
9%
Relapsing-remitting MS
8%
B Cell Subsets
8%
Neurofilament Light (NF-L)
8%
Healthy Controls
8%
Nave
7%
Immune Parameters
7%
Single nucleotide Polymorphism
7%
Progressive MS
7%
Autoreactivity
7%
Smokers
6%
CD25
6%
Lymphocytes
6%
Plasmablast
6%
Effector T Cells
6%
T Cell Response
6%
Alemtuzumab
6%
Randomized Controlled Trial
5%
Untreated Patients
5%
IgG Index
5%
B-cell Maturation Antigen
5%
CD49d
5%
Immunology and Microbiology
Multiple Sclerosis
100%
T Cell
46%
B Cell
44%
Cerebrospinal Fluid
35%
Relapsing Remitting Multiple Sclerosis
34%
CD20
22%
Myelin
18%
Cytotoxic T-Cell
16%
Follicular B Helper T Cells
15%
Fumaric Acid Dimethyl Ester
15%
T-Helper Cell
15%
Natalizumab
13%
Cell Activity
10%
Lymphocyte
10%
B Lymphocyte Subpopulation
8%
T Cell Subset
8%
CD25
7%
Immunocompetent Cell
7%
Single Nucleotide Polymorphism
7%
Memory T Cell
6%
Plasmablast
6%
Th17 Cell
6%
CD8
6%
Primary Progressive Multiple Sclerosis
6%
B Cell Maturation Antigen
6%
Allele
6%
Central Nervous System
5%
Interleukin 17
5%
CD49d
5%
Alemtuzumab
5%
Memory B Cell
5%
Interleukin 2 Receptor
5%
Cell Population
5%
Neuroscience
Multiple Sclerosis
66%
T Cell
55%
Relapsing Remitting Multiple Sclerosis
29%
Intrathecal
29%
B Cell
28%
Primary Progressive Multiple Sclerosis
18%
CD8
14%
Natalizumab
13%
Neurofilament Light Chain
12%
CD4
9%
Flow Cytometry
9%
Myelin Basic Protein
9%
CD20
9%
Cell Activity
9%
Randomized Controlled Trial
6%
Placebo
6%
B Lymphocyte Subpopulation
6%
CD27
6%
Lymphocyte
6%
Central Nervous System
5%
